Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial

Mostrar otras versiones (1)

BACKGROUND: The ability to quantify an immune response after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential. This study assessed the clinical utility of the quantitative Roche Elecsys(®) Anti-SARS-CoV-2 S assay (ACOV2S) using samples from the 2019-nCoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochum, Simon, Kirste, Imke, Hortsch, Sayuri, Grunert, Veit Peter, Legault, Holly, Eichenlaub, Udo, Kashlan, Basel, Pajon, Rolando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509092/
https://www.ncbi.nlm.nih.gov/pubmed/34642699
http://dx.doi.org/10.1101/2021.10.04.21264521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509092/
https://www.ncbi.nlm.nih.gov/pubmed/34642699
http://dx.doi.org/10.1101/2021.10.04.21264521

Ejemplares similares